SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Mesoblast Webinar Highlights Ryoncil Use After Steroids in Pediatric GVHD

Mesoblast said it hosted a key opinion leader webinar this week on expert perspectives on graft-versus-host disease. The headline says the webinar highlighted Ryoncil use as a first-line treatment after steroids for pediatric acute GVHD.

MSB

Related stories